scholarly article | Q13442814 |
P356 | DOI | 10.1080/03639045.2016.1254238 |
P698 | PubMed publication ID | 27796140 |
P50 | author | Mahdi Gholami | Q59684841 |
Maliheh Safavi | Q60370722 | ||
P2093 | author name string | Farid Abedin Dorkoosh | |
Ebrahim Saadat | |||
Fatemeh Ravar | |||
Mahboobeh Pordeli | |||
Pouya Dehghankelishadi | |||
P2860 | cites work | Solubilization of the novel anionic amphiphilic photosensitizer TPCS 2a by nonionic Pluronic block copolymers | Q48880147 |
Development and Validation of Rapid Stability-Indicating RP-HPLC-DAD Method for the Quantification of Lapatinib and Mass Spectrometry Analysis of Degraded Products. | Q53160975 | ||
Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil. | Q53596582 | ||
Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer. | Q54768529 | ||
On the receiving end--patient perception of the side-effects of cancer chemotherapy. | Q55062718 | ||
Can nanomedicines kill cancer stem cells? | Q27022017 | ||
Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers | Q28282826 | ||
Nanoparticle therapeutics: an emerging treatment modality for cancer | Q29615628 | ||
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 | ||
Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. | Q30475533 | ||
A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro | Q30871548 | ||
Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles | Q31065397 | ||
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) | Q33194199 | ||
The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles | Q33237619 | ||
Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles | Q33327252 | ||
Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues | Q34219275 | ||
Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery | Q34783697 | ||
Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells. | Q35134791 | ||
Caveolae: mining little caves for new cancer targets | Q35190153 | ||
Pluronic F127 polymeric micelles for co-delivery of paclitaxel and lapatinib against metastatic breast cancer: preparation, optimization and in vitro evaluation | Q35284749 | ||
Combination drug delivery approaches in metastatic breast cancer | Q35955198 | ||
Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores | Q36368107 | ||
Micellar nanocarriers: pharmaceutical perspectives | Q36655007 | ||
Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer | Q37113921 | ||
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 | Q37119716 | ||
Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells | Q37263033 | ||
Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases | Q37274044 | ||
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer | Q37327582 | ||
The PKB/AKT pathway in cancer | Q37705534 | ||
Incorporation of lapatinib into lipoprotein-like nanoparticles with enhanced water solubility and anti-tumor effect in breast cancer | Q39186813 | ||
Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles | Q39245832 | ||
Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. | Q39254937 | ||
Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor | Q39430827 | ||
A synergistic interaction between lapatinib and chemotherapy agents in a panel of cell lines is due to the inhibition of the efflux pump BCRP. | Q39648670 | ||
Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo. | Q39736030 | ||
Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel. | Q39767302 | ||
Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines. | Q39842390 | ||
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells | Q40321992 | ||
Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone) copolymer as a carrier for paclitaxel | Q40649166 | ||
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents | Q43761469 | ||
Enhanced uptake and cytotoxity of folate-conjugated mitoxantrone-loaded micelles via receptor up-regulation by dexamethasone | Q45064323 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | micelles | Q421110 |
P304 | page(s) | 390-398 | |
P577 | publication date | 2016-11-14 | |
P1433 | published in | Drug Development and Industrial Pharmacy | Q5308840 |
P1476 | title | In vitro and in vivo evaluation of paclitaxel-lapatinib-loaded F127 pluronic micelles | |
P478 | volume | 43 |
Q64998055 | Cytotoxic Effect of Paclitaxel and Lapatinib Co-Delivered in Polylactide-co-Poly(ethylene glycol) Micelles on HER-2-Negative Breast Cancer Cells. |
Q89909885 | Evaluation of micelles incorporated into thermosensitive hydrogels for intratumoral delivery and controlled release of docetaxel: A dual approach for in situ treatment of tumors |
Search more.